CAS 41613-16-5

C8 Galactosylceramide (d18:1/8:0)

CAS: 41613-16-5

C8 Galactosylceramide boosts doxorubicin efficacy in cancer cells, not healthy ones, and affects splenocyte growth and cytokine release at 100-1,000 ng/ml.

Formula: C₃₂H₆₁NO₈

Colore e forma: Solid

Peso molecolare: 587.83

Ref: TM-T36323

Octanoyl-Galactosylceramide

CAS: 41613-16-5

Formula: C32H61NO8

Purezza: >99%

Colore e forma: Solid

Peso molecolare: 587.83

Ref: 48-56-2061